German pain medicines specialist Grünenthal has dipped another toe in the M&A waters with a $250 million agreement to buy US drugmaker Valinor Pharma. The deal is essentially a move to take ...
Who is Valinor Capital Partners SPV XXII, LLC? Valinor Capital Partners SPV XXII, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback